The new Rule 506 changes everything. The SEC has lifted an 80-year ban on general solicitation. Start-ups for the first time can use public advertising to sell private offerings. The new Rule 506 may prove to be the answer to the prayers of star-ups frustrated with existing fund sourcing platforms. But it also has hidden dangers that will cause many issuers to continue to use the "old Rule 506" 506(b)]. Among the new Rule 506 strengths: - The amount that can be raised is unlimited - There is no requirement for review of the offering under any Blue Sky laws (state securities regulations) - There is no review of the offering by the SEC - Solicitations can be online or offline - Solicitations can be made to anyone Sales (as opposed to solicitations) must be to accredited investors, and issuers must be able to verify that any actual investor is "accredited." Also, proposed rules will require issuers to send the SEC all marketing copy; as of this writing, however, there is no need to send copies of solicitation materials to the SEC (or to state regulators). Soon you will start to see: - Emails asking if you might be interested in learning about investing in someone's project - Videos of founders and entrepreneurs soliciting your interest in their projects - Links on websites inviting you to click through to learn more about an investment - Mobile apps with increasingly creative solicitation
Three recent events will prove seminal in the to-be-written history of the industry and finally announce a pathway for investors and entrepreneurs, sometimes now referred to "ganjapreneurs" or "cannabusinesses." -The U. S. Department of Justice has said it will not interfere with marijuana retail sales as long as all rules are followed and all taxes are paid. -The U.S. Treasury Department's Financial Crimes Enforcement Network issued formal guidance to banks on how to do business with marijuana companies. -The President of the United States compared marijuana to alcohol.
Make the right drug therapy decisions with the leading guide to applying pharmacotherapy principles to real-world clinical practiceThe perfect companion to DiPiro's Pharmacotherapy: A Pathophysiologic Approach, 12th EditionPharmacotherapy Casebook: A Patient-Focused Approach uses 150+ cases to help you build the clinical decision-making skills required to identify and resolve commonly encountered medication therapy problems encountered in daily practice. Providing a consistent, practical approach, this authoritative guide delivers everything you need to master patient communication, care plan development, and documenting interventions. Case chapters are organized into system sections that correspond to those of the companion textbook. The case-based approach makes this an ideal resource for PharmD, Nurse Practitioner, and other allied health courses.With each case you will learn how to:Identify actual or potential drug therapy problemsDetermine the desired therapeutic outcomeEvaluate therapeutic alternativesDesign an optimal individualized pharmacotherapeutic planDevelop methods to evaluate the therapeutic outcomeProvide patient educationCommunicate and implement the pharmacotherapeutic planEverything you need to develop expertise in pharmacotherapy decision-making:Realistic patient presentations include medical history, physical examination, and laboratory data, followed by a series of questions using a systemic, problem-solving approachCompelling range of cases—from the uncomplicated (a single disease state) to the complex (multiple disease states and drug-related problems)Coverage that integrates the biomedical and pharmaceutical sciences with therapeuticsAppendices containing valuable information on pharmacy abbreviations, laboratory tests, mathematical conversion factors, anthropometrics, and complementary and alternative therapiesContent that is ideal for both pharmacy and nurse practitioner markets
Three developments signal a new regulatory regime is on the way. -The U.S. Department of Justice announced it will not interfere with marijuana retail sales as long as all state and Federal rules are followed and all taxes are paid. -The U.S. Treasury Department's Financial Crimes Enforcement Network issued formal guidance to U.S. banks on how to do business with marijuana firms. -The President of the United States mentioned marijuana and alcohol in the same sentence. An enormous, quasi-dormant underground economy is awakening and large components are coming to the surface. Taylor West, deputy director of the 440-member National Cannabis Industry Association, said, "There is a whole canopy of products that goes beyond plants." He cites cannabis-infused foods and drinks, cannabis oils, butters, tinctures, and salves. New regulatory demands will spark other opportunities such as laboratories to test for impurities and software systems to track product from seed-to-sale. But make no mistake about it: Some investors in some of the publicly-held cannabis-connected companies detailed at www.hempinsiders.com will lose money.
Why does it keep growing? Jason and his wife have a perfect life. But when Jason notices a dark stain along the collar of his son's t-shirt, a new, creeping horror enters his perfect home. "Clegg's stories can chill the spine so effectively that the reader should keep paramedics on standby."- Dean Koontz, NY Times bestselling author. 30 pages in print. Additional book excerpts are included at the back of this ebook.
